New Orders for Reflect Scientific Freezers and Chillers Top $750K

Rhea-AI Summary

Reflect Scientific, Inc. (RSCF) announced $768,000 in new orders over the past 60 days for its Cryometrix cryogenic products. This includes $648,000 for ultra-cold freezers and $120,000 for solvent chillers. CEO Kim Boyce stated that the second quarter of 2021 shows strong demand for these products, which are vital for biopharmaceutical processing and CBD extraction from hemp. Reflect Scientific develops innovative cooling technologies for the biotechnology and pharmaceutical industries.

Positive

• New orders of $768,000 for Cryometrix products in 60 days.
• $648,000 from ultra-cold freezers and $120,000 from solvent chillers.
• Strong demand in Q2 2021 highlights market response.

Negative

• None.

OREM, Utah, June 22, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announced today that there had been $768,000 in new orders in the past 60 days for the Cryometrix cryogenic products.

Orders for the ultra-cold Cryometrix freezers were $648,000, with solvent chillers contributing another $120,000 over the past 60 days. Mr. Kim Boyce, CEO of Reflect Scientific Inc., commented, “The second quarter of 2021 is showing strong orders for the Cryometrix ultra-cold freezers as well as solvent chillers. These products are delighting our customers and the market is responding.” The patented liquid nitrogen powered freezers are instrumental in processing and storing high-value biopharmaceuticals. The solvent chillers are primarily used for the extraction of CBD from hemp biomass.

About Reflect Scientific, Inc.
Reflect Scientific, Inc., based in Orem, Utah, develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses. Visit www.reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the OTC Markets Group, LLC under the trading symbol “RSCF” and related prior filings by the Company that are referenced therein and contained in the EDGAR Archives of the Securities and Exchange Commission under the heading “Disclosure,” including those identified in such filings as “forward-looking statements.”

FAQ

What are the new orders for Reflect Scientific’s Cryometrix products?

Reflect Scientific reported $768,000 in new orders for Cryometrix products over the past 60 days.

What is the breakdown of the new orders reported by RSCF?

New orders included $648,000 for ultra-cold Cryometrix freezers and $120,000 for solvent chillers.

How is Reflect Scientific performing in Q2 2021?

Reflect Scientific is experiencing strong demand for its Cryometrix ultra-cold freezers and solvent chillers in Q2 2021.

What industries does Reflect Scientific serve?

Reflect Scientific provides products and services for the biotechnology, pharmaceutical, and transportation industries.